Genetic & Genomic MedicinemedRxivPreprint
Investigating CYP2C9*3 Polymorphisms in Patients with Neuropsychological Disorders through Pharmacogenomics Testing
Braa Elwaleed Mohamed Ahmed, Muhsin Konuk, Tayfun Gözler…·Abeer Azhary Sayed Abdoon
This study examines CYP2C9*3 polymorphisms in patients with neuropsychological disorders using pharmacogenomics testing and finds a higher frequency of *1/*1 genotype compared to *1/*3.
DOI 10.64898/2025.12.03.25340647